Personal information

No personal information available

Activities

Collapse all

Works (17)

Disrupting CD38-driven T cell dysfunction restores sensitivity to cancer immunotherapy

2024-02 | Preprint
DOI: 10.1101/2024.02.12.579184
PPR: PPR806941
Contributors: Revach O; Cicerchia AM; Shorer O; Petrova B; Anderson S; Park J; Chen L; Mehta A; Wright SJ; McNamee N et al.
Source: Self-asserted source
Lloyd BOD via Europe PubMed Central

Targeting PGLYRP1 promotes antitumor immunity while inhibiting autoimmune neuroinflammation.

Nature immunology
2023-10 | Journal article
DOI: 10.1038/s41590-023-01645-4
PMID: 37828379
Contributors: Schnell A; Huang L; Regan BML; Singh V; Vonficht D; Bollhagen A; Wang M; Hou Y; Bod L; Sobel RA et al.
Source: Self-asserted source
Lloyd BOD via Europe PubMed Central

B-cell-specific checkpoint molecules that regulate anti-tumour immunity.

Nature
2023-06 | Journal article
DOI: 10.1038/s41586-023-06231-0
PMID: 37344597
PMC: PMC10795478
Contributors: Bod L; Kye YC; Shi J; Torlai Triglia E; Schnell A; Fessler J; Ostrowski SM; Von-Franque MY; Kuchroo JR; Barilla RM et al.
Source: Self-asserted source
Lloyd BOD via Europe PubMed Central

Charting the cellular biogeography in colitis reveals fibroblast trajectories and coordinated spatial remodeling

2023-05 | Preprint
DOI: 10.1101/2023.05.08.539701
PPR: PPR657497
Contributors: Cadinu P; Sivanathan KN; Misra A; Xu RJ; Mangani D; Yang E; Rone JM; Tooley K; Kye Y; Bod L et al.
Source: Self-asserted source
Lloyd BOD via Europe PubMed Central

Metabolic modeling of single Th17 cells reveals regulators of autoimmunity.

Cell
2021-07 | Journal article
DOI: 10.1016/j.cell.2021.05.045
PMID: 34216539
PMC: PMC8621950
Contributors: Wagner A; Wang C; Fessler J; DeTomaso D; Avila-Pacheco J; Kaminski J; Zaghouani S; Christian E; Thakore P; Schellhaass B et al.
Source: Self-asserted source
Lloyd BOD via Europe PubMed Central

T Follicular Regulatory Cell-Derived Fibrinogen-like Protein 2 Regulates Production of Autoantibodies and Induction of Systemic Autoimmunity.

Journal of immunology (Baltimore, Md. : 1950)
2020-11 | Journal article
DOI: 10.4049/jimmunol.2000748
PMID: 33168576
PMC: PMC7725915
Contributors: Sungnak W; Wagner A; Kowalczyk MS; Bod L; Kye YC; Sage PT; Sharpe AH; Sobel RA; Quintana FJ; Rozenblatt-Rosen O et al.
Source: Self-asserted source
Lloyd BOD via Europe PubMed Central

Checkpoint Receptor TIGIT Expressed on Tim-1<sup>+</sup> B Cells Regulates Tissue Inflammation.

Cell reports
2020-07 | Journal article
DOI: 10.1016/j.celrep.2020.107892
PMID: 32668241
PMC: PMC7496220
Contributors: Xiao S; Bod L; Pochet N; Kota SB; Hu D; Madi A; Kilpatrick J; Shi J; Ho A; Zhang H et al.
Source: Self-asserted source
Lloyd BOD via Europe PubMed Central

Author Correction: The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity.

Cell research
2020-04 | Journal article
DOI: 10.1038/s41422-020-0285-x
PMID: 32086475
PMC: PMC7118137
Contributors: Schnell A; Bod L; Madi A; Kuchroo VK
Source: Self-asserted source
Lloyd BOD via Europe PubMed Central

Metabolic and Epigenomic Regulation of Th17/Treg Balance by the Polyamine Pathway

2020-01 | Preprint
DOI: 10.1101/2020.01.23.911966
PPR: PPR110087
Contributors: Wang C; Wagner A; Fessler J; Avila-Pacheco J; Karminski J; Thakore P; Zaghouani S; Pierce K; Bod L; Schnell A et al.
Source: Self-asserted source
Lloyd BOD via Europe PubMed Central

The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity.

Cell research
2020-01 | Journal article
DOI: 10.1038/s41422-020-0277-x
PMID: 31974523
PMC: PMC7118128
Contributors: Schnell A; Bod L; Madi A; Kuchroo VK
Source: Self-asserted source
Lloyd BOD via Europe PubMed Central

Emerging Role of IL-4-Induced Gene 1 as a Prognostic Biomarker Affecting the Local T-Cell Response in Human Cutaneous Melanoma.

The Journal of investigative dermatology
2018-07 | Journal article
DOI: 10.1016/j.jid.2018.06.178
PMID: 30048651
Contributors: Ramspott JP; Bekkat F; Bod L; Favier M; Terris B; Salomon A; Djerroudi L; Zaenker KS; Richard Y; Molinier-Frenkel V et al.
Source: Self-asserted source
Lloyd BOD via Europe PubMed Central

Inflammation drives nitric oxide synthase 2 expression by γδ T cells and affects the balance between melanoma and vitiligo associated melanoma.

Oncoimmunology
2018-07 | Journal article
DOI: 10.1080/2162402x.2018.1484979
PMID: 30228955
PMC: PMC6140581
Contributors: Douguet L; Bod L; Labarthe L; Lengagne R; Kato M; Couillin I; Prévost-Blondel A
Source: Self-asserted source
Lloyd BOD via Europe PubMed Central

IL-4-Induced Gene 1: A Negative Immune Checkpoint Controlling B Cell Differentiation and Activation.

Journal of immunology (Baltimore, Md. : 1950)
2017-12 | Journal article
DOI: 10.4049/jimmunol.1601609
PMID: 29288206
Contributors: Bod L; Douguet L; Auffray C; Lengagne R; Bekkat F; Rondeau E; Molinier-Frenkel V; Castellano F; Richard Y; Prévost-Blondel A
Source: Self-asserted source
Lloyd BOD via Europe PubMed Central

IL4-induced gene 1 promotes tumor growth by shaping the immune microenvironment in melanoma.

Oncoimmunology
2017-01 | Journal article
DOI: 10.1080/2162402x.2016.1278331
PMID: 28405502
PMC: PMC5384381
Contributors: Bod L; Lengagne R; Wrobel L; Ramspott JP; Kato M; Avril MF; Castellano F; Molinier-Frenkel V; Prévost-Blondel A
Source: Self-asserted source
Lloyd BOD via Europe PubMed Central

Nitric Oxide Synthase 2 Improves Proliferation and Glycolysis of Peripheral γδ T Cells.

PloS one
2016-11 | Journal article
DOI: 10.1371/journal.pone.0165639
PMID: 27812136
PMC: PMC5094591
Contributors: Douguet L; Cherfils-Vicini J; Bod L; Lengagne R; Gilson E; Prévost-Blondel A
Source: Self-asserted source
Lloyd BOD via Europe PubMed Central

Propranolol induces a favourable shift of anti-tumor immunity in a murine spontaneous model of melanoma.

Oncotarget
2016-11 | Journal article
DOI: 10.18632/oncotarget.12833
PMID: 27788481
PMC: PMC5363624
Contributors: Jean Wrobel L; Bod L; Lengagne R; Kato M; Prévost-Blondel A; Le Gal FA
Source: Self-asserted source
Lloyd BOD via Europe PubMed Central

Nitric oxide synthase 2 is involved in the pro-tumorigenic potential of γδ17 T cells in melanoma.

Oncoimmunology
2016-08 | Journal article
DOI: 10.1080/2162402x.2016.1208878
PMID: 27622078
PMC: PMC5007969
Contributors: Douguet L; Bod L; Lengagne R; Labarthe L; Kato M; Avril MF; Prévost-Blondel A
Source: Self-asserted source
Lloyd BOD via Europe PubMed Central
How many people are using ORCID?